Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-12-04 Sale | 2023-12-05 2:40 pm | Solid Biosciences Inc. | SLDB | Cumbo Alexander President and CEO | 11,757 | $2.7657 | $32,516 | 103,276 (Direct) | View |
| 2019-12-13 Sale | 2019-12-17 8:02 pm | Sarepta Therapeutics Inc. | SRPT | Cumbo Alexander EVP, Chief Commercial Officer | 42,000 | $125.5 | $5,271,000 | 27,312 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-13 Option Award | 2024-02-16 12:01 pm | N/A 2034-02-13 | Solid Biosciences Inc. | SLDB | Cumbo Alexander President and CEO | 360,375 | $0 | 360,375 (Direct) | View |
| 2023-12-02 Exercise | 2023-12-05 2:40 pm | N/A N/A | Solid Biosciences Inc. | SLDB | Cumbo Alexander President and CEO | 28,612 | $0 | 103,276 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 5:00 pm | N/A 2033-06-14 | Verve Therapeutics Inc. | VERV | Cumbo Alexander Director | 26,642 | $0 | 26,642 (Direct) | View |
| 2022-12-02 Option Award | 2022-12-05 5:46 pm | N/A 2032-12-02 | Solid Biosciences Inc. | SLDB | Cumbo Alexander President and CEO | 343,933 | $0 | 343,933 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 5:00 pm | N/A 2032-06-08 | Verve Therapeutics Inc. | VERV | Cumbo Alexander Director | 31,000 | $0 | 31,000 (Direct) | View |
| 2020-04-02 Disposition | 2020-04-03 09:01 am | N/A 2029-06-11 | Ra Pharmaceuticals Inc. | RARX | Cumbo Alexander Director | 40,000 | $0 | 0 (Direct) | View |
| 2020-02-28 Option Award | 2020-02-28 8:01 pm | N/A 2030-02-28 | Sarepta Therapeutics Inc. | SRPT | Cumbo Alexander EVP, Chief Commercial Officer | 44,200 | $0 | 49,508 (Direct) | View |
| 2019-12-13 Exercise | 2019-12-17 8:02 pm | 2016-09-09 2026-02-28 | Sarepta Therapeutics Inc. | SRPT | Cumbo Alexander EVP, Chief Commercial Officer | 32,706 | $0 | 27,312 (Direct) | View |
| 2019-12-13 Exercise | 2019-12-17 8:02 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Cumbo Alexander EVP, Chief Commercial Officer | 6,622 | $13.71 | 27,312 (Direct) | View |
| 2019-12-13 Exercise | 2019-12-17 8:02 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Cumbo Alexander EVP, Chief Commercial Officer | 26,084 | $26.24 | 27,312 (Direct) | View |
| 2019-06-11 Option Award | 2019-06-13 4:35 pm | N/A 2029-06-11 | Ra Pharmaceuticals Inc. | RARX | Cumbo Alexander Director | 15,000 | $0 | 15,000 (Direct) | View |